Christine L. Baker, JD, MPH, MBA

Senior Director, HTA Value & Evidence Team Lead, Sickle Cell Disease
Pfizer

Poster(s):

• (303) Estimation of period-based costs associated with individual chronic complications of rare inherited diseases, in the context of multimorbidity, using real-world data.
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST